10th Annual Meeting of the Neuroendocrinology Section of the German Society of Endocrinology (DGE)

Allolio, B.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Ardeleanu, C.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Arnold, R.

Long-acting somatostatin analogues and interferon-alpha in the treatment of neuroendocrine tumors: what is ascertained, what is unproven?

Arzt, E.

Novel targets for the treatment of ACTH-secreting tumors

Attanasio, A.

Growth hormone deficiency of childhood onset: developmental targets and adult risk

Avramidis, A.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Banerjee, A. K.

Carcinoid – rare presentation

Bano, G.

Suspected PIT-1 mutation in a UK kindred with short stature

Behl, C.

Corticotropin releasing hormone (CRH) is a neuroprotective peptide

Bettag, M.

Pure endoscopy in pituitary surgery – which is the chance of a hormonal cure in acromegaly?

Beuschlein, F.

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Bidlingmaier, M.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Case report: Estradiol lowers IGF-I in a 46 year old acromegalic female treated with pegvisomant

Binder, G.

Pituitary gland malformations – genetic and environmental factors

Birch, L.

Progesterone receptor: biochemical characterization and anatomical distribution in the brain of the lizard, Podarcis sicula

Borges, F.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Born, J.

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Bornemann, A.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Bouterfa, H.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Bruening, J. C.

Role of brain insulin receptor and control of body weight and reproduction

Buchfelder, M.

Unusal manifestation of a McCune-Albright syndrome

Buchmann, A.

Alcohol drinking but not psychosocial stress acutely affects ghrelin secretion in healthy volunteers

Buijs, R. M.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Busert, C.

Pure endoscopy in pituitary surgery – which is the chance of a hormonal cure in acromegaly?

Calaminus, G.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

Callies, F.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Cappabianca, P.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Caron, P.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Castillo, V.

Novel targets for the treatment of ACTH-secreting tumors

Cerovac, V.

Combination of rapamycin and somatostatin analogues for the treatment of nonfunctioning pituitary tumors

Chang, T. C.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Chara, K.

Influence of sweet perception during glucose ingestion on subsequent food intake

Awakening and counterregulatory response to hypoglycemia during early and late sleep

Chevrin, A.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Chrisoulidou, A.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Ciarcia, G.

Progesterone receptor: biochemical characterization and anatomical distribution in the brain of the lizard, Podarcis sicula

Ciubotaru, V.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Clement, A.

Corticotropin releasing hormone (CRH) is a neuroprotective peptide

Codorean, E.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Colaco, T.

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Colao, A.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Conrad, M.

The “principle of balance“: How do biological systems become homeostatic?

Brain enforced glucose homeostasis

Correa-de-Santana, E.

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Cruceru, M. L.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Cuneo, R. C.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

De Menis, E.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Deuss, U.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Dibbelt, L.

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Dieterle, C.

Alcohol drinking but not psychosocial stress acutely affects ghrelin secretion in healthy volunteers

Droste, M.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Ebner, F.

Surgical therapy of childhood craniopharyngiomas

Emser, A.

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

Engelbach, M.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Faldum, A.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

Farrall, A.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Faust, M.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Fehm, H. L.

The “principle of balance“: How do biological systems become homeostatic?

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

Brain enforced glucose homeostasis

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Finke, R.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Fischer, B.

The “principle of balance“: How do biological systems become homeostatic?

Brain enforced glucose homeostasis

Fliers, E.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Franco, J.

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Franz, H.

Dopamine agonist therapy in combination with somatostatin analogue treatment in patients with acromegaly: analysis of the German Acromegaly Registry

Frese, T.

The influence of insulin and glucose on norepinephrine stimulated pineal melatonin secretion

Freudenstein, D.

Status quo of stereotactic surgery in the management of cystic craniopharyngiomas

Surgical therapy of childhood craniopharyngiomas

Fritsche, A.

Insulin and brain – the physiology of a well known hormone revisited

Fuchs, A.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Gadelha, M. R.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Gallwitz, B.

The gut-brain axis and its implications for the therapy of type 2 diabetes

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Gebhardt, U.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

History and symptoms at primary diagnosis of childhood craniopharyngioma in 311 patients

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Gehring, H.

Effect of acute hypoxia on plasma leptin concentrations in men

Gilsbach, J. M.

Comparison of salivary cortisol concentrations using two different saliva collection methods

Greggersen, W.

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Grossman, A.

The treatment of neuroendocrine tumours with radionuclides

Gruenblatt, E.

Insulin resistant brain state: behavioural, neurochemical and genetical resemblance to sporadic Alzheimer's disease

Guerriero, G.

Progesterone receptor: biochemical characterization and anatomical distribution in the brain of the lizard, Podarcis sicula

Gutt, B.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Haering, H. U.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Amelioration of insulinoma symptoms in pregnancy

Hallschmid, M.

Influence of sweet perception during glucose ingestion on subsequent food intake

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Handwerker, G.

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

Hanisch, E.

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Hanspach, B.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Hanstein, R.

Corticotropin releasing hormone (CRH) is a neuroprotective peptide

Haq, M.

Suspected PIT-1 mutation in a UK kindred with short stature

Haupt, S.

Macroprolactinomas presenting with spontaneous cerebrospinal fluid rhinorrhea

Herrero y Calle, M.

LED auto registration in navigated endoscopic-transnasal pituitary surgery of microadenomas

Honegger, J.

Status quo of stereotactic surgery in the management of cystic craniopharyngiomas

Macroprolactinomas presenting with spontaneous cerebrospinal fluid rhinorrhea

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Surgical therapy of childhood craniopharyngiomas

Horger, M.

Amelioration of insulinoma symptoms in pregnancy

Hoyer, S.

Insulin resistant brain state: behavioural, neurochemical and genetical resemblance to sporadic Alzheimer's disease

Hubbe, U.

LED auto registration in navigated endoscopic-transnasal pituitary surgery of microadenomas

Hubold, C.

The “principle of balance“: How do biological systems become homeostatic?

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

Brain enforced glucose homeostasis

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Jacobeit, J.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Kahl, K. G.

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Kalentzi, C.

History and symptoms at primary diagnosis of childhood craniopharyngioma in 311 patients

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

Kalsbeek, A.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Kaltsas, G.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Karges, B.

Unusal manifestation of a McCune-Albright syndrome

Kaufmann, S.

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Kaulen, D.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Kern, W.

Effects of intranasal insulin on cognitive function and body composition

Kita, M.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Knispel, A.

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

Knittel, T.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Kolb, R.

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Koschker, A.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Kowarik, M.

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Kreier, F.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Kreitschmann-Andermahr, I.

Comparison of salivary cortisol concentrations using two different saliva collection methods

Kriesche, C.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Kroehne, H. J.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Kuge, M.

Changes of sleep related renin secretion after sleep deprivation in humans

Labeur, M.

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Novel targets for the treatment of ACTH-secreting tumors

Langejuergen, Y.

Comparison of salivary cortisol concentrations using two different saliva collection methods

Letterer, S.

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Machicao, F.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Mann, K.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Mathias, S.

Changes of sleep related renin secretion after sleep deprivation in humans

Mercado, M.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Mettenleiter, T. C.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Moericke, R.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Mohammed, N.

Carcinoid – rare presentation

Monteserin, J. L.

The NAD-dependent protein deacetylase Sirt1 is expressed in the human anterior pituitary gland and it regulates GH transcription

Muehlbauer, E.

The influence of insulin and glucose on norepinephrine stimulated pineal melatonin secretion

Mueller, H. L.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

History and symptoms at primary diagnosis of childhood craniopharyngioma in 311 patients

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Mueller-Stoever, S.

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Muessig, K.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Amelioration of insulinoma symptoms in pregnancy

Nussey, S.

Suspected PIT-1 mutation in a UK kindred with short stature

Oeffner, A.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Ogrezean, I.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Oltmanns, K. M.

Effect of acute hypoxia on plasma leptin concentrations in men

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Onofri, C.

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Paez-Pereda, M.

Novel targets for the treatment of ACTH-secreting tumors

Pais, I.

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Patocs, A.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Pecka, M.

Combination of rapamycin and somatostatin analogues for the treatment of nonfunctioning pituitary tumors

Pereira, P. L.

Amelioration of insulinoma symptoms in pregnancy

Peschke, E.

The influence of insulin and glucose on norepinephrine stimulated pineal melatonin secretion

Peters, A.

The “principle of balance“: How do biological systems become homeostatic?

Effect of acute hypoxia on plasma leptin concentrations in men

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

Brain enforced glucose homeostasis

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Petersenn, S.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Recent advances in medical therapy for acromegaly

Petrick, M.

Macroprolactinomas presenting with spontaneous cerebrospinal fluid rhinorrhea

LED auto registration in navigated endoscopic-transnasal pituitary surgery of microadenomas

Podoba, J.

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Pohl, F.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

Poll, E.

Comparison of salivary cortisol concentrations using two different saliva collection methods

Popescu, D. I.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Prins, G. S.

Progesterone receptor: biochemical characterization and anatomical distribution in the brain of the lizard, Podarcis sicula

Psaras, T.

Macroprolactinomas presenting with spontaneous cerebrospinal fluid rhinorrhea

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Quabbe, H. J.

Dopamine agonist therapy in combination with somatostatin analogue treatment in patients with acromegaly: analysis of the German Acromegaly Registry

Raducan, E.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Ranke, M. B.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

Are there remaining questions in growth hormone (GH) deficiency?

Rees, A.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Reincke, M.

Results of transsphenoidal surgery for Cushing's disease in a contemporary series

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Renner, U.

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Renovanz, M.

Status quo of stereotactic surgery in the management of cystic craniopharyngiomas

Riederer, P.

Insulin resistant brain state: behavioural, neurochemical and genetical resemblance to sporadic Alzheimer's disease

Ritz, R.

Status quo of stereotactic surgery in the management of cystic craniopharyngiomas

Roemmler, J.

Case report: Estradiol lowers IGF-I in a 46 year old acromegalic female treated with pegvisomant

Romijn, J. A.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Roth, C.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Rudolf, S.

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Safari, M.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

An open-label, prospective, multicenter study in patients with acromegaly to assess the safety, efficacy, and tolerability of octreotide LAR as primary therapy

Saller, B.

Predictors of the development of hypopituitarism after traumatic brain injury

Sauerwein, H. P.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Scheruebl, H.

Growth factor receptors as targets for novel treatment strategies of neuroendocrine tumors

Schmid, H. A.

Possible treatment option for patients with Prader-Willi Syndrome and Ghrelinoma

Schmid, S.

Influence of sweet perception during glucose ingestion on subsequent food intake

Schmoller, A.

Effect of acute hypoxia on plasma leptin concentrations in men

Schneider, H. J.

Dopamine agonist therapy in combination with somatostatin analogue treatment in patients with acromegaly: analysis of the German Acromegaly Registry

Predictors of the development of hypopituitarism after traumatic brain injury

Schneider, M.

Predictors of the development of hypopituitarism after traumatic brain injury

Schopohl, J.

Case report: Estradiol lowers IGF-I in a 46 year old acromegalic female treated with pegvisomant

Schroeder, S.

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Schroeder, U.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Schuessler, P.

Changes of sleep related renin secretion after sleep deprivation in humans

Schultes, B.

Influence of sweet perception during glucose ingestion on subsequent food intake

Effect of acute hypoxia on plasma leptin concentrations in men

AMPA receptor antagonist caroverine has no effect on hypoglycaemic counterregulation

NMDA receptor antagonist memantine increases neuroglycopenic symptoms during hypoglycaemia

Schumm-Draeger, P. M.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Schweiger, U.

Effect of acute hypoxia on plasma leptin concentrations in men

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Shah, M. J.

LED auto registration in navigated endoscopic-transnasal pituitary surgery of microadenomas

Siegmund, T.

Screening of the anterior pituitary function following traumatic brain injury or subarachnoidal hemorrhage

Sievers, C.

Dopamine agonist therapy in combination with somatostatin analogue treatment in patients with acromegaly: analysis of the German Acromegaly Registry

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Silva, A. P.

Possible treatment option for patients with Prader-Willi Syndrome and Ghrelinoma

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Simmgen, M.

Suspected PIT-1 mutation in a UK kindred with short stature

Soerensen, N.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Secondary narcolepsy may be a causative factor of increased daytime sleepiness in obese patients with childhood craniopharyngioma

Melatonin treatment in obese patients with childhood craniopharyngioma and increased daytime sleepiness

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

History and symptoms at primary diagnosis of childhood craniopharyngioma in 311 patients

High rates of early relapses after complete resection and early tumor progressions after incomplete resection of childhood craniopharyngioma – Update after three years of prospective evaluation in KRANIOPHARYNGEOM 2000 and study design of KRANIOPHARYNGEOM 2007

First experiences with bariatric surgery in patients with childhood craniopharyngioma and severe obesity recruited in KRANIOPHARYNGEOM 2000

Stalla, G. K.

The NAD-dependent protein deacetylase Sirt1 is expressed in the human anterior pituitary gland and it regulates GH transcription

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Dopamine agonist therapy in combination with somatostatin analogue treatment in patients with acromegaly: analysis of the German Acromegaly Registry

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Predictors of the development of hypopituitarism after traumatic brain injury

Combination of rapamycin and somatostatin analogues for the treatment of nonfunctioning pituitary tumors

Novel targets for the treatment of ACTH-secreting tumors

Stalla, J.

Novel targets for the treatment of ACTH-secreting tumors

Steffin, B.

Case report: Estradiol lowers IGF-I in a 46 year old acromegalic female treated with pegvisomant

Alcohol drinking but not psychosocial stress acutely affects ghrelin secretion in healthy volunteers

Steiger, A.

Changes of sleep related renin secretion after sleep deprivation in humans

Stöckelhuber, B. M.

Glucose homeostasis and visceral fat in female patients with major depressive disorder with and without comorbid borderline personality disorder

Strasburger, C. J.

Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma

T'Sjoen, G.

Primary octreotide LAR versus surgery in previously untreated acromegalic patients – an international, prospective, randomized, multicentre study

Tanase, C.

The function of vascular endothelial growth factor and basic fibroblast growth factor in pituitary adenomas

Tatagiba, M.

Status quo of stereotactic surgery in the management of cystic craniopharyngiomas

Surgical therapy of childhood craniopharyngiomas

Teske, C.

Quality of life (QoL) in childhood craniopharyngioma – Current status of the prospective multicenter study KRANIOPHARYNGEOM 2000 and results of a retrospective study on 185 long-term survivors

Theodoropoulou, M.

The NAD-dependent protein deacetylase Sirt1 is expressed in the human anterior pituitary gland and it regulates GH transcription

Integration of stimulatory and inhibitory signals in pituitary tumor cells through the PI3 kinase pathway

Expression of functionally active NOD1 and NOD2 in folliculostellate TtT/GF pituitary cells

Combination of rapamycin and somatostatin analogues for the treatment of nonfunctioning pituitary tumors

Novel targets for the treatment of ACTH-secreting tumors

Tsolakidou, K.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Uhr, M.

Alcohol drinking but not psychosocial stress acutely affects ghrelin secretion in healthy volunteers

Changes of sleep related renin secretion after sleep deprivation in humans

van Vugt, H.

Possible treatment option for patients with Prader-Willi Syndrome and Ghrelinoma

Veder, L. L.

Dual sympathetic and parasympathetic hypothalamic output to white adipose tissue

Ventzi, L.

Incidence of pituitary incidentalomas in patients with adrenal adenomas

Vlad, A. G.

The menopause a forth critical periode in evolution of the gonadotropin system – new understanding of a new therapeutic strategy

Vogel, U.

Amelioration of insulinoma symptoms in pregnancy

von Puttkamer, J.

Unusal manifestation of a McCune-Albright syndrome

von Rosen, F.

Predictors of the development of hypopituitarism after traumatic brain injury

Wabitsch, M.

Unusal manifestation of a McCune-Albright syndrome

Wallaschofski, H.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Warmuth-Metz, M.

Prognostic impact of hypothalamic involvement in patients with childhood craniopharyngioma – Results of a cross-sectional study and update on the prospective surveillance study KRANIOPHARYNGEOM 2000

Wass, J. A. H.

A treatment algorithm for acromegaly based on data from the UK Acromegaly Database

Webb, S. M.

Quality of Life – a tool to guide decision making in neuroendocrinology – development of AcroQoL

Wehrmann, M.

Amelioration of insulinoma symptoms in pregnancy

Weikel, J. C.

Changes of sleep related renin secretion after sleep deprivation in humans

Wiesner, T.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Will, B.

Surgical therapy of childhood craniopharyngiomas

Wiskirchen, J.

Amelioration of insulinoma symptoms in pregnancy

Woelfel, B.

Novel targets for the treatment of ACTH-secreting tumors

Wudy, S.

Unusal manifestation of a McCune-Albright syndrome

Wuester, C.

Preliminary results from the OASIS study: world-wide medical treatment practice in recently diagnosed acromegalic patients

Yagmur, E.

Comparison of salivary cortisol concentrations using two different saliva collection methods

Yassouridis, A.

Changes of sleep related renin secretion after sleep deprivation in humans

Zimmermann, U. S.

Alcohol drinking but not psychosocial stress acutely affects ghrelin secretion in healthy volunteers

Zuber, V.

Changes of sleep related renin secretion after sleep deprivation in humans

Šalković-Petrišić, M.

Insulin resistant brain state: behavioural, neurochemical and genetical resemblance to sporadic Alzheimer's disease